Literature DB >> 31364907

Laparoscopic Sleeve Gastrectomy: How Do I Do It.

Mariano Palermo1, Edgardo Serra1.   

Abstract

Background: Laparoscopic sleeve gastrectomy (LSG) is the most commonly performed bariatric procedure in the world. LSG is a safe and effective primary bariatric procedure with durable weight loss. We believe LSG should not be called "easy" and should be performed only by surgeons trained in bariatric surgery. Method: We describe the technique, step by step, we use to perform a sleeve gastrectomy (SG).
Results: The highlights of a safer SG systematization are based on minimum 36Fr bougie calibration, starting 4-5 cm from the pylorus, keeping ∼1 cm distance from esophagus. We routinely use staple line reinforcement by continuous suture. Conclusions: LSG is a safe and effective primary bariatric procedure with durable weight loss. It should be performed only by surgeons trained in bariatric surgery.

Entities:  

Keywords:  bariatric surgery; laparoscopy; obesity; sleeve gastrectomy

Mesh:

Year:  2019        PMID: 31364907     DOI: 10.1089/lap.2019.0452

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  4 in total

Review 1.  Follow-up after bariatric surgery: are we effective enough?

Authors:  Kamil Nurczyk; Chia-En Chan; Tomasz Skoczylas; Grzegorz Wallner
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2021-11-01       Impact factor: 1.627

2.  Longitudinal Gastrectomy for Nonbariatric Indications.

Authors:  Oluwatobi O Onafowokan; Aboubakr Khairat; Mohammad Jamal; Hemant Chatrath; Hugo J R Bonatti
Journal:  Minim Invasive Surg       Date:  2021-05-06

3.  Sleeve gastrectomy without bougie is safe and effective operation: case report.

Authors:  Zkria Atia Shekh; Abdulkafi Hasan Roqaia
Journal:  J Surg Case Rep       Date:  2020-06-19

4.  The Need and Safety of Mineral Supplementation in Adults with Obesity Post Bariatric Surgery-Sleeve Gastrectomy (SG).

Authors:  Agata Wawrzyniak; Monika Krotki
Journal:  Obes Surg       Date:  2021-08-04       Impact factor: 4.129

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.